Strengthening AI Regulation in Healthcare
On 10 September 2026, the National Commission into the Regulation of AI in Healthcare unveiled a comprehensive set of recommendations aimed at enhancing the regulatory framework for artificial intelligence in the UK’s healthcare sector. The objective is to ensure that AI applications remain safe, keep pace with technological advancements, and maintain the public’s trust.
Currently, AI technologies are being utilised within the NHS to detect serious health issues, such as strokes and skin cancers, at early stages. Additionally, AI is facilitating administrative tasks through voice-enabled systems, thereby allowing healthcare professionals to devote more time to patient care. The Commission’s recommendations are designed to expand the benefits of AI to a larger patient population, positioning the UK as a pioneering environment for innovation, utilisation by healthcare providers, and patient engagement.
Professors Alastair Denniston and Henrietta Hughes, both practising NHS physicians, highlighted the significance of the Commission’s work, stating, “The National Commission into the Regulation of AI in Healthcare aims to define the future landscape of AI-driven healthcare and how regulation can help shape this vision. Our focus is on creating a healthcare system that is increasingly supported by technology while remaining centred around the needs of people.”
New Regulatory Framework for AI
Lawrence Tallon, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), expressed his support for the report, noting that it provides a detailed framework for regulating AI in healthcare. He emphasised the potential of AI to enhance and expedite patient care while freeing up clinicians to focus on the human elements of their practice. However, he cautioned that these advancements can only be realised through a modern regulatory framework that prioritises patient safety and fosters public and professional confidence. Tallon expressed gratitude to the diverse group of contributors who participated in the Commission’s efforts to outline a roadmap for the future.
The independent Commission, established by the MHRA in September 2025, comprises a wide array of experts in health, regulation, and AI, including international contributors from countries like the USA and Singapore. Over the course of a year, the Commission engaged with more than 12,000 stakeholders, including patients, clinicians, healthcare leaders, and technology developers, marking this as the largest engagement on healthcare technology regulation in the UK to date. Complementary in-depth research conducted by the Health Foundation provided valuable insights into the public’s expectations and priorities regarding AI regulation in healthcare.
Public Support and Key Recommendations
The findings underscored substantial public support for integrating AI into healthcare, contingent upon stringent safety standards, effective human oversight, and transparency regarding AI use in patient care. In response, the Commission put forth several key recommendations aimed at aligning AI deployment with public expectations.
Among these recommendations is the proposal for the MHRA to implement a system of staged authorisations for new AI models, akin to the learner driver ‘L-plates’. This approach would allow for new AI technologies to be introduced under close supervision, demonstrating their real-world safety and effectiveness before receiving full approval. This phased strategy aims to ensure that UK patients gain early access to innovative AI solutions while maintaining stringent risk management protocols.
Additionally, the Commission advocates for continuous monitoring of AI-enabled medical devices throughout their operational lifecycle rather than relying solely on initial approvals. This ongoing scrutiny will help to safeguard patients as AI technologies evolve, ensuring that regulators can take timely action in response to any emerging issues.
Enhancing Transparency and Accountability
To further bolster public confidence, the Commission recommends that individuals should have easy access to safety information regarding specific AI-enabled medical devices, including any adverse incidents. This initiative builds upon existing tools, such as the MHRA’s interactive Drug Analysis Profiles, allowing patients to access reliable information. Furthermore, the recommendations emphasise the importance of keeping patients informed about the utilisation of AI in their care, fostering a transparent environment as AI becomes increasingly integrated into NHS services.
Stronger regulatory powers for the MHRA are also proposed, enabling decisive action in instances where AI systems do not meet patient safety expectations. The government and the MHRA are now tasked with carefully evaluating these recommendations, with an official response anticipated in the near future.
Voices of the Commission
Professor Alastair Denniston, Chair of the National Commission, articulated the need for innovation, stating, “We innovate with the belief that future healthcare can surpass the standards of today. However, every innovation, including AI, must earn its place and the trust of the public. It is imperative that these technologies demonstrate safety, effectiveness, and tangible benefits to patients, healthcare staff, and the broader NHS.”
Professor Henrietta Hughes, Deputy Chair of the Commission, echoed this sentiment, stressing that patients feel safer when they are informed of AI’s role in their care, and that AI should enhance rather than replace clinician involvement. She affirmed that the recommendations are designed to prioritise patient safety while optimising healthcare delivery.
Expert opinions from various stakeholders, including academic figures and health organisation leaders, underscore the necessity of a regulatory environment that is both proportionate and robust, enabling the safe integration of AI technologies into healthcare. The emphasis remains on fostering public trust and ensuring accountability in the deployment of AI.
Looking Ahead
The insights gathered from the Commission, coupled with the diverse perspectives of those in the healthcare sector, highlight a clear desire for AI to play a significant role in enhancing patient care. However, this progress hinges on establishing a regulatory framework that addresses safety, transparency, and human oversight. The recommendations set forth represent a significant step in navigating the complexities of AI in healthcare while ensuring that patient safety and public trust remain at the forefront of innovation.
The full report, along with additional resources, will be made available on 10 September 2026, marking a pivotal moment in the evolution of AI regulation within the UK’s healthcare system.